Home LiteratureArticle Details
PMID: 2252013 Published · ppublish English Editorial Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. Review

The who's and when's of therapy for Helicobacter pylori.

The American journal of gastroenterology ·Vol. 85 ·No. 12 ·1990-12-00 ·Pages 1552-5

Graham DY, Börsch GM

Abstract

暂无摘要

MeSH Terms
Anti-Bacterial Agents/therapeutic use Bismuth/therapeutic use Drug Resistance, Microbial Drug Therapy, Combination Helicobacter Infections/complications,diagnosis,drug therapy Helicobacter pylori/drug effects Humans Peptic Ulcer/complications,drug therapy
Chemicals
Anti-Bacterial Agents Bismuth
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Graham D Y
Börsch G M
Article Info
Journal
The American journal of gastroenterology
Abbr.
Am J Gastroenterol
ISSN
0002-9270
Published
1990-12-00
Pages
1552-5
Language
English
Region
United States
NLM ID
0421030
Subset
IM
Grants
NIDDK NIH HHS · DK 39919 · United States
Corrections
CommentIn
PMID: 2058644
External Links
PubMed source View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2